A study to investigate the effect of a drug to treat Angina pectoris

Registry ID

EUCTR2012-001584-77

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Menarini International Operations Luxembourg S.A.

Start date

2012-10-08

Last update

2026-08-16

Conditions

• Stable Angina Pectoris

Summary

Primary objective of this study is to evaluate the efficacy of ranolazine treatment in terms of changes of wall motion abnormalities in ischemic areas in patients treated with ranolazine compared to patients treated with placebo at follow-up magnetic resonance examination after five weeks of ranolazine treatment.

Locations

• , , Germany

Related clinical trials

• TTE Improves Clinical Management of Stable Chest Pain
• The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
• Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

View on source registry